logo
logo
Globe Life Inc.

Globe Life Inc.

NYSE•GL
CEO: Mr. Frank Martin Svoboda
セクター: Financial Services
業種: Insurance - Life
上場日: 1980-10-01
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
連絡先情報
3700 South Stonebridge Drive, P. O. Box 8080, McKinney, TX, 75070-8080, United States
972-569-4000
www.home.globelifeinsurance.com
時価総額
$11.48B
PER (TTM)
10.0
14.6
配当利回り
0.7%
52週高値
$152.71
52週安値
$109.38
52週レンジ
80%
順位13Top 2.2%
6.8
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
強い • 6.8 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$1.52B+0.00%
直近4四半期の推移

EPS

$3.35+0.00%
直近4四半期の推移

フリーCF

$0.00+0.00%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Net Income Growth Net income totaled $895M for nine months ended September 30, 2025, reflecting a strong 10% increase over the prior year period.
Diluted EPS Jump Diluted EPS reached $10.77, marking a significant 21% increase compared to $8.93 in the prior year period.
Total Premium Income Rises Total premium grew 5% to $3.65B, driven by Health premium increasing 8% to $1.13B year-to-date.
Strong Equity Growth Shareholders' equity increased to $5.69B by September 30, 2025, supported by strong net income results.

リスク要因

Litigation Uncertainty Securities class action and derivative suits are pending; ultimate loss amount cannot be reasonably estimated at this time.
Equity Volatility Risk Inconsistent accounting for assets versus liabilities causes undue volatility in reported shareholders' equity presentation.
Investment Unrealized Loss Fixed maturity portfolio currently holds a net unrealized loss position of $1.1B as of September 30, 2025.
Economic Headwinds Inflation, geopolitical events, and regulatory changes present ongoing uncertainties impacting business assumptions.

見通し

Share Repurchase Focus Excess cash flow primarily used for share repurchases, $515M utilized year-to-date 2025 for open market purchases.
Capital Adequacy Target Targeting consolidated Company Action Level RBC ratio of 300% to 320% for 2025 to support current ratings.
Core Operations Positive Expect continued positive trends in core operations, achieving operating ROE generally in the mid-teens for the medium term.
Investment Strategy Continue seeking highest risk-adjusted returns on fixed maturity acquisitions for portfolio, holding securities to maturity.

同業比較

売上高 (TTM)

MetLife, Inc.MET
$76.13B
+8.6%
Lincoln National CorporationLNC
$18.21B
+1.2%
Unum GroupUNM
$12.94B
+1.2%

粗利益率 (最新四半期)

Grupo Financiero Galicia S.A.GGAL
62.7%
+2.0pp
Kinsale Capital Group, Inc.KNSL
55.9%
+1.2pp
MetLife, Inc.MET
30.5%
-12.4pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
MET$50.94B15.212.0%2.6%
UNM$11.99B16.36.7%0.0%
GL$11.48B10.021.3%0.0%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
1.0%
緩やかな成長
4四半期純利益CAGR
1.5%
収益性の緩やかな改善
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい

深度リサーチ

次回決算:2026年4月28日
|
EPS:-
|
売上高:-
財務レポート
財務データ
全年度

  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月5日|
    売上高: $1.51B+4.0%
    |
    EPS: $4.81+39.4%
    予想を上回る

  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年8月6日|
    売上高: $1.48B+2.9%
    |
    EPS: $3.09+12.4%
    予想を下回る

  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月7日|
    売上高: $1.48B+4.5%
    |
    EPS: $3.05+12.5%
    予想を下回る

  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年2月26日|
    売上高: $5.78B+6.1%
    |
    EPS: $11.99+17.4%
    予想を上回る

  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月6日|
    売上高: $1.46B+5.2%
    |
    EPS: $3.45+26.8%
    予想を上回る

  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月7日|
    売上高: $1.44B+8.6%
    |
    EPS: $2.75+21.7%
    予想を下回る

  • Form 10-Q - Q1 2024

    会計期末: 2024年3月31日|提出日: 2024年5月8日|
    売上高: $1.42B+29.5%
    |
    EPS: $2.71+16.8%
    予想通り

  • Form 10-K - FY 2023

    会計期末: 2023年12月31日|提出日: 2024年2月28日|
    売上高: $5.45B+4.2%
    |
    EPS: $10.21+35.2%
    予想を下回る